Kiyosue A, Dunn JP, Cui X, Hickey A, et al. Safety and efficacy analyses across age and body mass index subgroups in East Asian participants with type 2 diabetes in the phase 3 tirzepatide studies (SURPASS program). Diabetes Obes Metab 2022 Dec 22. doi: 10.1111/dom.14952.
PMID: 36545807